224 related articles for article (PubMed ID: 30734588)
1. Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive
Kruzik A; Koppensteiner H; Fetahagic D; Hartlieb B; Dorn S; Romeder-Finger S; Coulibaly S; Weber A; Hoellriegl W; Horling FM; Scheiflinger F; Reipert BM; de la Rosa M
Hum Gene Ther Methods; 2019 Apr; 30(2):35-43. PubMed ID: 30734588
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome.
Aronson SJ; Veron P; Collaud F; Hubert A; Delahais V; Honnet G; de Knegt RJ; Junge N; Baumann U; Di Giorgio A; D'Antiga L; Ginocchio VM; Brunetti-Pierri N; Labrune P; Beuers U; Bosma PJ; Mingozzi F
Hum Gene Ther; 2019 Oct; 30(10):1297-1305. PubMed ID: 31502485
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a passive immunity mouse model to quantitatively analyze the impact of neutralizing antibodies on adeno-associated virus-mediated gene transfer.
Sun L; Tu L; Gao G; Sun X; Duan J; Lu Y
J Immunol Methods; 2013 Jan; 387(1-2):114-20. PubMed ID: 23063691
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.
Li P; Boenzli E; Hofmann-Lehmann R; Helfer-Hungerbuehler AK
PLoS One; 2019; 14(3):e0212811. PubMed ID: 30897117
[TBL] [Abstract][Full Text] [Related]
5. Prediction of adeno-associated virus neutralizing antibody activity for clinical application.
Wang M; Crosby A; Hastie E; Samulski JJ; McPhee S; Joshua G; Samulski RJ; Li C
Gene Ther; 2015 Dec; 22(12):984-92. PubMed ID: 26125606
[TBL] [Abstract][Full Text] [Related]
6. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
Sun J; Hua B; Chen X; Samulski RJ; Li C
Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.
Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP
Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480
[TBL] [Abstract][Full Text] [Related]
8. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
Li C; Narkbunnam N; Samulski RJ; Asokan A; Hu G; Jacobson LJ; Manco-Johnson MJ; Monahan PE;
Gene Ther; 2012 Mar; 19(3):288-94. PubMed ID: 21697954
[TBL] [Abstract][Full Text] [Related]
10. Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort.
Perocheau DP; Cunningham S; Lee J; Antinao Diaz J; Waddington SN; Gilmour K; Eaglestone S; Lisowski L; Thrasher AJ; Alexander IE; Gissen P; Baruteau J
Hum Gene Ther; 2019 Jan; 30(1):79-87. PubMed ID: 30027761
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum.
Dai Y; Dong H; Gleason C; Mora J; Kolaitis G; Balasubramanian N; Surapaneni S; Kozhich A; Jawa V
AAPS J; 2023 Apr; 25(3):35. PubMed ID: 37012501
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.
Leborgne C; Latournerie V; Boutin S; Desgue D; Quéré A; Pignot E; Collaud F; Charles S; Simon Sola M; Masat E; Jouen F; Boyer O; Masurier C; Mingozzi F; Veron P
Cell Immunol; 2019 Aug; 342():103780. PubMed ID: 29571923
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
[TBL] [Abstract][Full Text] [Related]
14. Successful AAV8 readministration: Suppression of capsid-specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease.
Choi SJ; Yi JS; Lim JA; Tedder TF; Koeberl DD; Jeck W; Desai AK; Rosenberg A; Sun B; Kishnani PS
J Gene Med; 2023 Aug; 25(8):e3509. PubMed ID: 36994804
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Adeno-Associated Virus Neutralizing Antibodies in Males with Duchenne Muscular Dystrophy.
Verma S; Nwosu SN; Razdan R; Upadhyayula SR; Phan HC; Koroma AA; Leguizamo I; Correa NS; Kuipa M; Lee D; Vanderford TH; Gardner MR
Hum Gene Ther; 2023 May; 34(9-10):430-438. PubMed ID: 36324212
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors.
Liu Q; Huang W; Zhang H; Wang Y; Zhao J; Song A; Xie H; Zhao C; Gao D; Wang Y
Gene Ther; 2014 Aug; 21(8):732-8. PubMed ID: 24849042
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.
Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Pogoda JM; Provost R; Guerrero J; Hajjar RJ; Zsebo KM
Gene Ther; 2016 Mar; 23(3):313-9. PubMed ID: 26699914
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays.
Gorovits B; Fiscella M; Havert M; Koren E; Long B; Milton M; Purushothama S
AAPS J; 2020 Jan; 22(2):24. PubMed ID: 31907680
[TBL] [Abstract][Full Text] [Related]
20. Preexisting Neutralizing Antibodies to Adeno-Associated Virus Capsids in Large Animals Other Than Monkeys May Confound In Vivo Gene Therapy Studies.
Calcedo R; Franco J; Qin Q; Richardson DW; Mason JB; Boyd S; Wilson JM
Hum Gene Ther Methods; 2015 Jun; 26(3):103-5. PubMed ID: 26067568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
